Hunan Kerey Pharmaceutical Co., Ltd. – Trademark Portfolio
Entity Type: 03
Hunan Kerey Pharmaceutical Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HNPHYTO and VEGABASED.
Caixing Rd, Economic Development Zone,
Xinshao County, Shaoyang 422900 Hunan
Showing of trademarks Trademarks
Trademark Classifications
Hunan Kerey Pharmaceutical Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Hunan Kerey Pharmaceutical Co., Ltd. have?
Hunan Kerey Pharmaceutical Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Hunan Kerey Pharmaceutical Co., Ltd. file in?
Hunan Kerey Pharmaceutical Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Hunan Kerey Pharmaceutical Co., Ltd.'s most well-known trademarks?
Hunan Kerey Pharmaceutical Co., Ltd.'s registered trademark portfolio includes well-known marks such as HNPHYTO and VEGABASED. These are among 2 currently registered trademarks in the portfolio.
What is Hunan Kerey Pharmaceutical Co., Ltd.'s trademark registration success rate?
Hunan Kerey Pharmaceutical Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.